Summary of Classification and Labelling
Notified classification and labelling
General Information
EC / List no.
![]() |
Name |
CAS Number
![]() |
---|---|---|
213-086-1 | N-(hydroxymethyl)methacrylamide | 923-02-4 |
Notified classification and labelling according to CLP criteria
Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
---|---|---|---|---|---|---|---|---|---|---|---|
Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
Acute Tox. 4 | H302 | H302 |
GHS07 GHS08 Wng |
Note D
|
State/Form
|
7 | ![]() |
View details | |||
Skin Sens. 1B | H317 | H317 | |||||||||
STOT SE 2 | H371 (Nervous system) (oral) | H371 (AFFECTED ORGANS...) | |||||||||
STOT RE 2 | H373 (Nervous system) (oral) | H373 (AFFECTED ORGANS...) | |||||||||
Acute Tox. 4 | H302 | H302 |
GHS07 GHS08 Wng |
State/Form
|
87 | View details | |||||
Skin Sens. 1B | H317 | H317 | |||||||||
STOT SE 2 | H371 (other:Nervous s...) | H371 | |||||||||
STOT SE 2 | H371 (Nervous system) | H371 | |||||||||
STOT RE 2 | H373 (other:Nervous s...) | H373 | |||||||||
STOT RE 2 | H373 (Nervous system) | H373 | |||||||||
Acute Tox. 3 | H301 | H301 |
GHS06 Dgr |
38 | View details | ||||||
Acute Tox. 4 | H302 | H302 |
GHS07 GHS08 Wng |
31 | View details | ||||||
Skin Sens. 1B | H317 | H317 | |||||||||
STOT SE 2 | H371 (other:Nervous s...) (oral) | H371 (May cause damag...) | |||||||||
STOT RE 2 | H373 (other:Nervous s...) (oral) | H373 (May cause damag...) | |||||||||
Not Classified | 16 | ||||||||||
H302 |
GHS07 Wng |
6 | View details | ||||||||
Acute Tox. 4 | H312 | H312 | |||||||||
Acute Tox. 4 | H332 |
Number of Aggregated Notifications: 6